|
|
Volumn 9, Issue 6, 2010, Pages 423-
|
|
Trial watch: Adaptive BATTLE trial uses biomarkers to guide lung cancer treatment
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEXAROTENE;
CYCLIN D1;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
K RAS PROTEIN;
SORAFENIB;
VANDETANIB;
VASCULOTROPIN RECEPTOR 2;
CLINICAL TRIAL;
DISEASE MARKER;
DRUG RESPONSE;
GENE EXPRESSION;
GENE MUTATION;
GENOTYPE;
HUMAN;
LUNG NON SMALL CELL CANCER;
PRIORITY JOURNAL;
SHORT SURVEY;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS, PHASE II AS TOPIC;
HUMANS;
LUNG NEOPLASMS;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 77953145401
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3199 Document Type: Short Survey |
|
Times cited : (14)
|
|
References (0)
|